Price
$3.57
Decreased by -5.05%
Dollar volume (20D)
1.41 M
ADR%
3.98
Earnings report date
Aug 6, 2025
Shares float
66.23 M
Shares short
3.81 M [5.75%]
Shares outstanding
85.58 M
Market cap
321.78 M
Beta
0.18
Price/earnings
N/A
20D range
3.16 3.83
50D range
2.46 3.83
200D range
2.46 3.86

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections.

Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV).

It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir.

Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 12, 25 -0.40
Increased by +46.67%
-0.41
Increased by +2.44%
Feb 26, 25 -0.40
Increased by +14.89%
-0.29
Decreased by -38.12%
Nov 7, 24 -0.37
Increased by +7.50%
-0.49
Increased by +24.49%
Aug 7, 24 -0.48
Decreased by -41.18%
-0.76
Increased by +36.84%
May 14, 24 -0.75
Decreased by -74.42%
-0.61
Decreased by -22.95%
Feb 28, 24 -0.47
Decreased by -14.63%
-0.50
Increased by +6.00%
Nov 8, 23 -0.40
Decreased by -300.00%
-0.48
Increased by +16.67%
Aug 8, 23 -0.34
Increased by +10.53%
-0.47
Increased by +27.66%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 0.00
Decreased by N/A%
-34.27 M
Increased by +45.75%
Decreased by N/A%
Decreased by N/A%
Dec 31, 24 0.00
Decreased by N/A%
-33.54 M
Increased by +14.35%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-31.15 M
Increased by +6.01%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-40.52 M
Decreased by -43.78%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-63.17 M
Decreased by -78.11%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 0.00
Decreased by N/A%
-39.16 M
Decreased by -13.75%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-33.14 M
Decreased by -310.89%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-28.18 M
Increased by +10.06%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY